Participants

Absco Therapeutics
Alexandria
Alloy Therapeutics
Andreessen Horowitz
Aquilo Partners
Arbor Biotechnologies
Arcturus Therapeutics
Arena BioWorks
Arrakis Therapeutics
AstraZeneca
Atlas Venture
Axonis Therapeutics
Banc of California
Blackbird Laboratories
Boston Children’s Hospital
Breakout Ventures
CEC Capital Group
Citizens Private Bank
Concerto Biosciences
DeepLook Medical
Delix Therapeutics
Delphia Therapeutics
DLA Piper
Droplet Biosciences
Eikonizo Therapeutics
Eledon Pharmaceuticals
Enveda
Entact Bio
Entrada Therapeutics
Evotec
Garuda Therapeutics
General Proximity

GlycoMimetics
Gordian Ventures
GrayBella Capital
GV
Halloran Consulting Group
Harvard Medical School
HC Bioscience
HDAX Therapeutics
Hevolution
Immunscope
Incubate Coalition
Ipsen
Jefferson River Capital
Johnson & Johnson Innovation -
JJDC
KiraGen Bio
Kojin Therapeutics
Kynexis THerapeutics
Larkspur Biosciences
Lucy Therapeutics
Luminary Therapeutics
Lumira Ventures
Lybra Bio
Lyndra Therapeutics
Lytica Therapeutics
Martrisome Bio
Merck
Neptune Bio
NextRNA Therapeutics
Normunity

Nova Nordisk
Novita Pharmaceuticals
Nucleate
Owkin
Oxford Finance
PAQ Therapeutics
Pending AI
Riboway Therapeutics
Pretzel Therapeutics
Psivant Therapeutics
RA Capital Management
Rapport Therapeutics
ReConstruct Bio
ROME Therapeutics
Sanofi
Sante
Satellite Bio
Seaport Therapeutics
SLAM BioTherapeutics
Souffle
SpyBiotech
Syntis Bio
Takeda
Two Bear Capital
Vertex Ventures HC
Versatope Therapeutics
Vigil Neuroscience
WilmerHale
Women's Digital Health Network
Worldwide Clinical Trials